Compounds, compositions and methods for treating neuropsychiatric disorders
OwnerJay W. Pettegrew, Samuel Gershon +1inventors
InventorsJay W. Pettegrew, Samuel Gershon, Kanagasabai Panchalingam
Life of this patent
Estimating the term…
Loading patent…
OwnerJay W. Pettegrew, Samuel Gershon +1inventors
InventorsJay W. Pettegrew, Samuel Gershon, Kanagasabai Panchalingam
Estimating the term…
Acetyl-L-carnitine (ALCAR) and L-carntine (LCAR) are nutraceuticals with indications in treating a variety of mental health disorders. A metabolomics-guided bioprocess method is presented to enhance ALCAR and LCAR formation in germinating plant seeds. Metabolic fluxes are manipulated by germination in bioreactors to increase oxygen availability as well as provide an aseptic environment to alter carbohydrate consumption and feedback repress gluconeogenesis. Large shifts in sunflower seed fatty acid, phospholipid and high-energy metabolism change the germination environment and these metabolic changes lead to an approximate 1000-fold increase in natural LCAR and ALCAR production by the seeds. The resulting LCAR and ALCAR products from the seeds are used for treating mental health disorders including Alzheimer's disease, geriatric depression, non-geriatric depression and schizophrenia.
A method for producing a pharmaceutical composition comprising:
A method for producing L-camitine (LCAR) and acetyl-L-camitine (ALCAR), comprising:
A method for producing L-camitine (LCAR) and/or acetyl-L-camitine (ALCAR), comprising:
Dependencies are inferred from the claim text.